CRISPR Therapeutics Q1 2026 Earnings Slight EPS Miss as Clinical Pipeline Progresses THO Q1 2026 Earnings Massive EPS Beat Drives Positive Market Response Ready Capital Corporation Q1 2026 Earnings Deep Earnings Miss Highlights Operational Headwinds GEOS Q1 2026 Earnings WiderThanExpected Loss and Revenue Disruption Pressure Shares KURA Q1 2026 Earnings EPS Misses Estimates as ClinicalStage Biotech Reports WiderThanExpected Loss SPRU Q1 2026 Earnings EPS Loss of 016 Per Share No Revenue Disclosed